Page 1 of Clinical Trials for randomized phaseII, 17718 Total Matches
- 1RecruitingLast Updated: May 15, 2012Condition(s): Non Small Cell Lung Carcinoma
- 2RecruitingLast Updated: May 17, 2012Condition(s): Colon Cancer
- 3RecruitingLast Updated: February 3, 2012Condition(s): Breast Neoplasms
- 4TerminatedLast Updated: January 7, 2008Condition(s): Prostate Cancer
- 5CompletedLast Updated: May 15, 2012Condition(s): Breast Cancer
- 6RecruitingLast Updated: November 28, 2011Condition(s): Breast Cancer
- 7CompletedLast Updated: December 5, 2011Condition(s): Metastatic Pancreatic Cancer
- 8TerminatedLast Updated: November 10, 2011Condition(s): Breast Cancer
- 9RecruitingLast Updated: March 14, 2012Condition(s): Hairy Cell Leukemia
- 10RecruitingLast Updated: June 5, 2009Condition(s): Hormone-Sensitive Breast Cancer; Breast Cancer
- 11Active, not recruitingLast Updated: March 23, 2012Condition(s): Colorectal Cancer
- 12Active, not recruitingLast Updated: January 29, 2009Condition(s): Breast Cancer
- 13RecruitingLast Updated: March 21, 2012Condition(s): Recurrent Glioblastoma
- 14CompletedLast Updated: March 3, 2008Condition(s): Prostatic Neoplasm
- 15RecruitingLast Updated: January 6, 2011Condition(s): Advanced Hepatocellular Carcinoma (HCC) Stage C According to BCLC Classification Restricted to Child-Pugh Class A/B (5-7 Points).
- 16CompletedLast Updated: May 9, 2012Condition(s): Triple Negative Locally Advanced Non-resectable Breast Cancer; Metastatic Breast Cancer
- 17RecruitingLast Updated: April 13, 2012Condition(s): Patients Must Have Histologically or Cytologically Confirmed Non-squamous Cell, Non Small Cell Carcinoma of the Lung.; Patient Must Have Measurable Stage IV Disease (Includes M1a, M1b Stages or Recurrent Disease).
- 18RecruitingLast Updated: April 30, 2012Condition(s): Metastatic Breast Cancer
- 19RecruitingLast Updated: October 30, 2007Condition(s): Ovarian Neoplasms
- 20RecruitingLast Updated: August 15, 2011Condition(s): Recurrent Non Small Cell Lung Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=randomized+phaseII
